MyAverix Finance
TWO · Consumer Cyclical
Li Kang Biomedical Co Ltd (6242)
Travel Services
Li Kang Biomedical Co Ltd (6242) is listed on TWO in the Consumer Cyclical sector. Industry: Travel Services. As of 2026-03-29, reported market cap is $1.19B, P/E ratio is 14.24, net margin is 14.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 6242
Li Kang Biomedical Co Ltd (6242) — FAQ
What is Li Kang Biomedical Co Ltd's market cap?
Li Kang Biomedical Co Ltd (6242) has a reported market cap of $1.19B (data as of 2026-03-29).
What is 6242's P/E ratio?
The price-to-earnings (P/E) ratio for Li Kang Biomedical Co Ltd (6242) is 14.24 (data as of 2026-03-29).
Does Li Kang Biomedical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Li Kang Biomedical Co Ltd (6242). Check the MyAverix Finance app for the latest dividend data.
What sector is Li Kang Biomedical Co Ltd in?
Li Kang Biomedical Co Ltd (6242) is classified in the Consumer Cyclical sector (Travel Services industry).
What exchange is 6242 listed on?
6242 is listed on TWO.
What is Li Kang Biomedical Co Ltd's net margin?
Li Kang Biomedical Co Ltd (6242) reports a net margin of 14.2% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.